loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

List of Ibrutinib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Dr. Reddy's Laboratories Limited (1)

02 Dr.Reddy¿s Laboratories Limited (1)

03 Wavelength Enterprises LTD (1)

04 Assia Chemical Industries Ltd. - Teva Tech Site (1)

05 Catalent Micron Technologies, Inc. (1)

06 Hetero Labs Limited (1)

07 Lonza Guangzhou Nansha LTD (1)

08 MSN Laboratories Private Limited (4)

09 Natco Pharma Limited (1)

10 SHILPA PHARMA LIFESCIENCES LIMITED (1)

11 ScinoPharm Taiwan Ltd. (3)

12 Shanghai Huilun Jiangsu Pharmaceutical Co., Ltd. (1)

13 Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd (1)

filter

01 IBRUTINIB (2)

02 Ibrutinib (9)

03 Ibrutinib (Form-A) (1)

04 Ibrutinib (Form-C) (1)

05 Ibrutinib (Form-M5) (1)

06 Ibrutinib HFCC (1)

07 Ibrutinib(Amorphous) (1)

08 Ibutinib (1)

09 ibrutinib (1)

filter

01 China (1)

02 France (1)

03 India (9)

04 Israel (2)

05 Taiwan (3)

06 U.S.A (1)

07 Blank (1)

URL Supplier Web Content
ibrutinib
POWDER (1kg/kg)
BULK INGREDIENT
58175-0602
2014-12-30
2024-12-31
URL Supplier Web Content
Ibrutinib HFCC
POWDER (100kg/100kg)
BULK INGREDIENT
63415-0531
2022-11-29
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ibrutinib (Form-M5)
POWDER (1kg/kg)
BULK INGREDIENT
54893-0102
2020-09-05
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ibrutinib (Form-C)
POWDER (1kg/kg)
BULK INGREDIENT
54893-0082
2018-11-30
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ibrutinib(Amorphous)
POWDER (1kg/kg)
BULK INGREDIENT
54893-0046
2016-05-23
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ibrutinib (Form-A)
POWDER (1kg/kg)
BULK INGREDIENT
54893-0049
2016-07-25
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ibrutinib
POWDER (100kg/100kg)
BULK INGREDIENT
42185-7078
2016-02-26
2023-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Lonza Guangzhou Nansha LTD

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
IBRUTINIB
POWDER (1kg/kg)
BULK INGREDIENT
40006-040
2012-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 936563-96-1 / Ibrutinib API manufacturers, exporters & distributors?

Ibrutinib manufacturers, exporters & distributors 1

100

PharmaCompass offers a list of Ibrutinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibrutinib manufacturer or Ibrutinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibrutinib manufacturer or Ibrutinib supplier.

PharmaCompass also assists you with knowing the Ibrutinib API Price utilized in the formulation of products. Ibrutinib API Price is not always fixed or binding as the Ibrutinib Price is obtained through a variety of data sources. The Ibrutinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ibrutinib

Synonyms

936563-96-1, Pci-32765, Imbruvica, Pci 32765, Ibrutinib (pci-32765), Pci-32765 (ibrutinib)

Cas Number

936563-96-1

Unique Ingredient Identifier (UNII)

1X70OSD4VX

About Ibrutinib

Ibrutinib is an orally bioavailable, small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon oral administration, ibrutinib binds to and irreversibly inhibits BTK activity, thereby preventing both B-cell activation and B-cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. The expression of BTK in tumor cells is also associated with increased proliferation and survival.

Ibrutinib Manufacturers

A Ibrutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibrutinib, including repackagers and relabelers. The FDA regulates Ibrutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibrutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ibrutinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ibrutinib Suppliers

A Ibrutinib supplier is an individual or a company that provides Ibrutinib active pharmaceutical ingredient (API) or Ibrutinib finished formulations upon request. The Ibrutinib suppliers may include Ibrutinib API manufacturers, exporters, distributors and traders.

click here to find a list of Ibrutinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ibrutinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ibrutinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Ibrutinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Ibrutinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Ibrutinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ibrutinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Ibrutinib suppliers with NDC on PharmaCompass.

Ibrutinib Manufacturers | Traders | Suppliers

Ibrutinib Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY